Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Tumor-Agnostic 1 Lymphoid 1 Breast 1

Conditions

Breast Neoplasms 5 Dyspareunia 2 Arthralgia 2 Vaginitis 1 Sexual Dysfunction, Physiological 1 Osteoporosis 1 Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1

Interventions

Paclitaxel 26 pembrolizumab 24 Docetaxel 20 Capecitabine 19 Fulvestrant 17 Trastuzumab 16 Anastrozole 15 Cyclophosphamide 14 Lapatinib 13 Letrozole 11 Carboplatin 11 Radiotherapy 10 Doxorubicin 10 palbociclib 9 Therapeutics 9 Nivolumab 9 Exercise 9 Gemcitabine 8 Cisplatin 8 Blood Specimen Collection 8 Tamoxifen 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 abemaciclib 6 Vinorelbine 6 Standard of Care 6 Fluorouracil 6 atezolizumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Testosterone × Breast × Clear all

NCT00497458 2009-04-09

ART2

Havah Therapeutics Pty Ltd

Phase 2 Unknown

Breast Neoplasms, Neoplasms, Osteoporosis, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡